View Single Post
  #11  
Old Sun Aug 28, 2011, 12:12 PM
Greg H Greg H is offline
Member
 
Join Date: Sep 2010
Location: North Carolina
Posts: 660
Quote:
Originally Posted by tytd View Post
I've been intrigued by Birgitta's good response to low dose Thalidomide but you don't hear many of the experts recommending that here in the U.S. I know Revlimid is the supposed next-generation drug but is it really any better than low dose Thalidomide? I'm not sure how the costs compare either. You might ask Dr. Olnes about this.
Hi Tytd!

I will ask Dr. Olnes about this. If thalidomide is cheaper, one might wonder whether the profit motive is at play.

I fully expect, since Revlimid is not approved yet for non-5q, that I will be doing a clinical trial, even if that's my next choice. I think I'll do some searching on Thalidomide for MDS in clinical trials.gov.

Thanks much!

Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
Reply With Quote